Evaluation of Retinoblastoma According to Histological Grading, TNM Staging and Age at Presentation
Keywords:
Retinoblastoma, Histological grading, TNM staging, Age, Optic nerve, Rb1 geneAbstract
Objective: To evaluate retinoblastoma, according to histological grades, TNM staging and age at presentation.
Materials and Methods: This cross sectional study was conducted in Department of Pathology BMSI- JPMC Karachi from
1st January 2009 to 31st December 2013 during which a total of 80 cases of retinoblastoma were received. Out of which 68 were
reviewed and morphological diagnosis was done on H&E staining. Histological grades and TNM staging were categorized.
The data was analyzed by using SPSS version 22.
Results: In 80 cases of retinoblastoma the mean age of patients was 3.64 years with 3-4 years (53.75%) of age being the
commonest. Amongst 68 cases, well differentiated retinoblastoma were seen in 7.35%, moderately differentiated 11.76%, poorly
differentiated 26.47% and undifferentiated 51.41% cases. Varied pattern of TNM staging were observed. Majority (60.29%)
in stage IV followed by 19.11% in stage I and 10.29% each in TNM stage II and III. Regional lymph node metastasis was seen
in 4/68 cases (5.88%) while 3/68 (4.41%) showed distant (CNS) metastasis. All these cases (7/7) were in TNM stage IV with
majority showing grade 4 (75%) and grade 3 (25%) histology.
Conclusion: Evaluation of retinoblastoma showed that commonest age group was 3-4 years. Majority of retinoblastoma cases
were undifferentiated (G4) followed by poorly differentiated (G3). While in TNM staging system varied pattern was observed,
majority were in stage IV followed by Stage I. Majority of lymph node and distant metastasis were seen in grade 4 histology
and all of them were in TNM stage IV.Evaluation of Retinoblastoma According to Histological
Grading, TNM Staging and Age at Presentation
References
Chintagumpala M, Barrios PC, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: Review of current manag-ement. Available at www. The oncologist com. J onco-log.2007; 12:1237-46
Arif M, Iqbal Z, Islam ZU. Retinoblastoma in NWFP (KPK), Pakistan .J Ayub Med Coll Abbottabad 2009; 2 1(4):60-2
Jijelava KP, Grossniklans H.E. Diffuse anterior retinob-lastoma. A review, Available at www, Saudi Ophthal jo-urnal com. Saudi J Ophth 2013; 27:135-9
Wu -D, Li Y, Song G, Zhang D, Shaw N, Liu Z-J. Crystal structure of human esterase D; a potential genetic marker of retinoblastoma FASEB J 2009; 23:1-7
Orjuela MA, Titievsky L, Lui X, Ortiz MR, Castaneda VP, Lecona E et al. Fruit and vegetable intake during pregnancy and risk for development of sporadic retinob-lastoma. Cancer epidemiology, biomarkers Prev 2005; 14(6):1433-40
Akhiwu W O, Igbe A P. Epidemiology of retinoblastoma. J Pedi Ophth Strab 2009; 46:288-93
Mclean I W, Burnier MN, Zimmerman LE, Jakobiec FA. Tumors of the eye and ocular adnexae. Armed Forces institute of patho Washington.1994; 97-135
Graaf P D, Goricke S, Rodjan F, Galluzzi P, Maeder P, Castelijns JA et al. Guidelines for imaging retinoblastoma: Imaging principles and MRI standardization. J Ped Radi 2012; 42:2-14
Oweye JFA, Afolayan EAO, Popoola DSA. Retinoblasto-ma-a clinic-pathological study in Ilorin, Nigeria. Afr J Health Sci 2005; 12:94-100
Kleinerman R A, Tucker MA, Tarone R E, Abramson DH, Seddon J M, Stovall M et al. Risk of new cancer after radiotherapy in long-term survivors of retinoblast-oma; an expected follow-up. J Clin Onco 2005; 23(10):2 227-79
Kleinerman R A, Schonfeld S J, Tucker M.A. Sarcomas in hereditary retinoblastoma. Available at http// www clinical sarcoma research. Com. J Clin Sarc.2012; 2-15
Jr BW, Schefler AC. Second malignancies in retinobla-stoma; the real problem. Available at 2014; 23-38
Yeole BB, Advani S. Retinoblastoma: An epidemiological appraisal with reference to a population in Mumbai Ind-ia, Bombay cancer registry Tata memorial Hosp Mumbai. Asian Pcif J Can Preven 2002; 3:17-21
Girardet A, Hamamah S, Anahory T, Dechaud H, Sarda P, Hedon B et al. First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsa-tellite markers. Available at http;//molehr.ox/ ford jour-nal.org, Mole Hum Rep J.2003; 9:111-6
Li Z, Wu X, Li J, Yao L, Sun L, Shi Y, et al. Antitumor act-ivity of celastrol nano particles in a xenograft retinoblasto-ma tumor model. Int J Nano Med 2012; 7:2389-98
Jurkiewicz E, Rutynowska O, Perek D. Trilateral retino-blastoma: Diagnosis using magnetic Resonance Imaging. J Pedi Canc 2012; 3:185-92
Islam F, Zafer S N, Siddiqui S N, Khan A, Clinical Co-urse of Retinoblastoma. JCPSP 2013 vol. 23(8):566-9
Diciommo D, Gallie B, Bremner R. Retinoblastoma: The disease, gene and protein provide critical lead to under stand cancer. Available at http:// www. Ideal lib-rary, Com. J can bio .2000; 10:255-69
Jia L, Li C, Yuan H, Gong F. Clinical value of CD24 expr-ession in retinoblastoma, J Bio Med Bio Tech 2012; 10:1-6
Rodrigues KES, Latorre MDRO, de Camargo B. Delayed diagnosis in retinoblastoma. J De Pedi 2004; 80(6):511-6
Antoneli C B G, Steinhorst F, Ribeiro K de C B, Novaes P E R, Chonjniak M M M, Arias V et al. Extraocular Retinoblastoma; A 13- Year Experience, American Can-cer Society 2003; 1292-8
Rosai J, Ackerman. Surgical pathology, Elsevier New Del-hi India. 10th Ed. 2011; 2; Eye and ocular adnexae. 2490-3
Grossniklaus H E, Kivela T, Harbour J W, Finger P T. Protocol for the examination of specimens from patients with retinoblastoma. Based on AJCC/UICC TNM .Oph-thalmic Retinoblastoma 2009; 1-16
Skuta GL, Cantor L, Band WJS. Ophthalmic Pathology and intraocular Tumors, Basic and clinical sciences course Canada. American Academy of ophthalmology. 2012-2013; Retinoblastoma, 299-09, 342-4
American Cancer Society Retinoblastoma. www.cancer Org 2014; 1-48
Fletcher C D M. Diagnostic Histopathology of Tumors, Elsevier Shanghai China 4th Ed, 2013; 2; Tumor of CNS, Eye and Ocular Adnexa. 1998-99, 2107- 9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Syed Muhammad Ishaq, Shahnaz Imdad Kehar, Noshaba Rahat, Abdullah Jan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
